The AI Alchemist: Michelle Chen Is Writing the Code for Future Medicines
Traditional drug discovery is slow, costly, and often fails. Insilico Medicine’s Chief Business Officer, trained in biology and mentored by Nobel laureates, is helping lead the charge into a new era where generative AI designs drugs faster than ever thought possible. Forget the image of lone scientists painstakingly mixing chemicals in a lab, hoping for […]
The AI Alchemist: Michelle Chen Is Writing the Code for Future Medicines Read More »












